CompletedPhase 3ACTRN12611000717954

Efficacy of clorpactin('registered trademark (R)) in bladder pain syndrome/interstitial cystitis: a randomised placebo-controlled trial

Efficacy of clorpactin(R) in bladder pain syndrome/interstitial cystitis: a randomised placebo-controlled trial


Sponsor

Mercy Hospital for Women

Enrollment

54 participants

Start Date

Mar 1, 2012

Study Type

Interventional

Conditions

Summary

A randomised trial assessing the efficacy of Clorpactin instillation in women with Bladder pain syndrome/Interstitial cystitis


Eligibility

Sex: FemalesMin Age: 18 YearssMax Age: 70 Yearss

Plain Language Summary

Simplified for easier understanding

This trial tests whether Clorpactin (a bladder wash medication) is effective for treating bladder pain syndrome, also known as interstitial cystitis. It enrolls women aged 18 to 70 who have been diagnosed with this painful bladder condition. The study compares Clorpactin against a placebo to measure improvements in pain and bladder symptoms.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Clorpactin (sodium oxychlorosene) 0.4% solution (2gm in 500ml sterile water) given as a single intravesical instillation under general anaesthetic

Clorpactin (sodium oxychlorosene) 0.4% solution (2gm in 500ml sterile water) given as a single intravesical instillation under general anaesthetic


Locations(1)

VIC, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12611000717954